Premium
Artivion Inc (AORT)
NYSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Ms. Amy D. HortonVP & CAO | -901,00 | 34,04k | Vente | 37,78 | 139,09k | -0,64% |
| 2026-03-03 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -12,81k | 485,73k | Vente | 37,78 - 38,00 | 185,10k | -6,47% |
| 2026-03-03 | Dr. Marshall S. StantonInitié | -2,15k | 81,18k | Vente | 37,78 | 60,10k | -3,45% |
| 2026-03-03 | Mr. John E. DavisSenior VP & Chief Commercial Officer | -4,57k | 172,75k | Vente | 37,78 | 230,79k | -1,94% |
| 2026-03-03 | Mr. Lance A. BerryEVP, COO, CFO & Treasurer | -6,32k | 238,59k | Vente | 37,78 | 210,83k | -2,91% |
| 2026-03-03 | Mr. James Patrick MackinChairman, President & CEO | -17,89k | 675,69k | Vente | 37,78 | 947,28k | -1,85% |
| 2026-03-02 | Ms. Amy D. HortonVP & CAO | -641,00 | 24,37k | Vente | 38,02 | 132,51k | -0,48% |
| 2026-03-02 | Dr. Marshall S. StantonInitié | -1,51k | 57,53k | Vente | 38,02 | 40,41k | -3,61% |
| 2026-03-02 | Mr. James Patrick MackinChairman, President & CEO | -14,91k | 566,99k | Vente | 38,02 | 848,21k | -1,73% |
| 2026-03-02 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -2,18k | 83,01k | Vente | 38,02 | 170,11k | -1,27% |
| 2026-03-02 | Mr. Lance A. BerryEVP, COO, CFO & Treasurer | -5,18k | 196,89k | Vente | 38,02 | 176,27k | -2,85% |
| 2026-03-02 | Mr. John E. DavisSenior VP & Chief Commercial Officer | -2,78k | 105,86k | Vente | 38,02 | 206,52k | -1,33% |
| 2026-02-23 | Ms. Amy D. HortonVP & CAO | -2,56k | 94,69k | Vente | 35,69 - 37,59 | 133,16k | -1,89% |
| 2026-02-23 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -4,75k | 175,27k | Vente | 35,69 - 37,59 | 172,29k | -2,68% |
| 2026-02-23 | Dr. Marshall S. StantonInitié | -3,68k | 136,01k | Vente | 35,69 - 37,59 | 41,92k | -8,07% |
| 2026-02-23 | Mr. James Patrick MackinChairman, President & CEO | -34,90k | 1,29M | Vente | 35,69 - 37,59 | 863,13k | -3,89% |
| 2026-02-23 | Mr. Lance A. BerryEVP, COO, CFO & Treasurer | -9,47k | 347,31k | Vente | 35,69 - 37,59 | 181,45k | -4,96% |
| 2026-02-23 | Mr. John E. DavisSenior VP & Chief Commercial Officer | -5,85k | 215,88k | Vente | 35,69 - 37,59 | 209,31k | -2,72% |
| 2025-12-15 | Mr. John E. DavisSenior VP & Chief Commercial Officer | -5,00k | 225,55k | Vente | 45,11 | 193,84k | -2,51% |
| 2025-12-08 | Ms. Amy D. HortonVP & CAO | -4,57k | 203,08k | Vente | 44,42 | 130,06k | -3,40% |
| 2025-12-03 | Mr. James Patrick MackinChairman, President & CEO | -30,92k | 489,82k | Derivative Exercise and Sale | 29,62 - 45,46 | 800,99k | - |
| 2025-12-03 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -7,32k | 331,37k | Vente | 45,30 | 156,09k | -4,48% |
| 2025-12-02 | Mr. James Patrick MackinChairman, President & CEO | -30,92k | 492,85k | Derivative Exercise and Sale | 29,62 - 45,56 | 800,99k | - |
| 2025-12-01 | Ms. Amy D. HortonVP & CAO | -750,00 | 0,00 | Other Disposition | - | 134,63k | -0,55% |
| 2025-11-20 | Dr. Marshall S. StantonInitié | -50,76k | 1,56M | Derivative Exercise and Sale | 11,03 - 45,35 | 44,75k | - |
| 2025-11-20 | Dr. Marshall S. StantonInitié | -11,89k | 524,74k | Vente | 44,14 | 44,75k | -20,99% |
| 2025-11-18 | Ms. Elizabeth A. HoffIndependent Director | -4,20k | 189,41k | Vente | 45,10 | 27,19k | -13,38% |
| 2025-11-14 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -12,79k | 197,75k | Derivative Exercise and Sale | 29,62 - 45,17 | 163,41k | - |
| 2025-11-14 | Mr. John E. DavisSenior VP & Chief Commercial Officer | -12,79k | 195,64k | Derivative Exercise and Sale | 29,62 - 45,17 | 198,84k | - |
| 2025-11-17 | Ms. Amy D. HortonVP & CAO | -6,00k | 274,38k | Vente | 45,73 | 135,38k | -4,24% |
| 2025-11-13 | Ms. Amy D. HortonVP & CAO | -3,48k | 159,68k | Vente | 45,86 | 141,38k | -2,40% |
| 2025-11-13 | Mr. John E. DavisSenior VP & Chief Commercial Officer | -6,56k | 300,97k | Vente | 45,86 | 198,84k | -3,20% |
| 2025-11-13 | Mr. James Patrick MackinChairman, President & CEO | -34,21k | 1,57M | Vente | 45,86 | 800,99k | -4,10% |
| 2025-11-13 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -5,76k | 264,19k | Vente | 45,86 | 163,41k | -3,41% |
| 2025-11-13 | Dr. Marshall S. StantonInitié | -4,99k | 228,97k | Vente | 45,86 | 56,64k | -8,10% |
| 2025-11-11 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -10,00k | 351,50k | Derivative Exercise and Sale | 11,03 - 46,18 | 169,17k | - |
| 2025-11-10 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -2,96k | 132,07k | Vente | 44,62 | 169,17k | -1,72% |
| 2025-11-10 | Mr. James Patrick MackinChairman, President & CEO | -17,58k | 784,40k | Vente | 44,62 | 835,20k | -2,06% |
| 2025-11-10 | Mr. John E. DavisSenior VP & Chief Commercial Officer | -3,37k | 150,50k | Vente | 44,62 | 205,41k | -1,62% |
| 2025-11-10 | Ms. Amy D. HortonVP & CAO | -1,79k | 79,82k | Vente | 44,62 | 144,86k | -1,22% |
| 2025-11-10 | Dr. Marshall S. StantonInitié | -2,57k | 114,49k | Vente | 44,62 | 61,63k | -4,00% |
| 2025-08-27 | Dr. Marshall S. StantonInitié | -18,20k | 600,47k | Derivative Exercise and Sale | 11,03 - 44,02 | 64,20k | - |
| 2025-08-25 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -10,00k | 333,40k | Derivative Exercise and Sale | 11,03 - 44,37 | 172,13k | - |
| 2025-08-15 | Mr. James Patrick MackinChairman, President & CEO | -12,50k | 528,99k | Vente | 42,32 | 852,78k | -1,44% |
| 2025-08-12 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -16,98k | 284,69k | Derivative Exercise and Sale | 26,24 - 43,01 | 172,13k | - |
| 2025-08-12 | Ms. Jean F. HollowaySenior VP, General Counsel, CCO & Corporate Secretary | -6,38k | 274,50k | Vente | 43,02 | 172,13k | -3,57% |
| 2025-08-12 | Mr. John E. DavisSenior VP & Chief Commercial Officer | -10,80k | 188,31k | Derivative Exercise and Sale | 26,24 - 43,67 | 208,78k | - |
| 2025-06-17 | Juniper Investment Company, LLCSociété | -233,72k | 9,54M | Vente | 29,62 - 42,36 | 390,79k | -37,42% |
| 2025-08-08 | Ms. Amy D. HortonVP & CAO | -7,99k | 70,89k | Derivative Exercise and Sale | 29,62 - 38,49 | 146,65k | - |
| 2025-06-17 | Dr. Marshall S. StantonInitié | -15,00k | 442,50k | Automatic Disposition | 29,50 | 64,20k | -18,94% |
| 2025-06-13 | Dr. Marshall S. StantonInitié | -26,13k | 743,13k | Automatic Disposition | 28,42 - 28,47 | 79,20k | -24,81% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
